Physician profile

Robert S Clark

Oral & Maxillofacial Surgery · Lexington, KY

NPI 1215962394

$3,893.98

in general payments reported to CMS, 2019-2025

8 companies · $11.33 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$1,129.33
Food and Beverage$506.04

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Geistlich Pharma, North America, INC. $1,782.55 2019-2024 Geistlich Bio-Oss Collagen, Geistlich Bio-Gide
A-Dec, INC. $1,501.90 2019-2021
Nobel Biocare USA $277.41 2019-2023 Nobelactive
Keystone Dental INC. $145.20 2021
Stryker Corporation $126.74 2019
Ace Surgical Supply Co., INC. $30.55 2022
Salvin Dental Specialties, INC. $18.30 2020
Align Technology, INC. $11.33 2025 Invisalign

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert S Clark

$3,893.98

in general payments reported 2019-2025

Years
2019-2025
Top company
Geistlich Pharma, North America, INC.

https://glasscript.com/doctor/100983/robert-s-clark

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.